Laboratory Corporation of America Holdings (LH) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.

Total Cash From Operating Activities Chart for Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings (LH) operating cash flow for FY2025 was USD 1.6B, a 3.4% change from FY2024. Laboratory Corporation of America Holdings's operating cash flow grew from USD 71.8M in 1989 to USD 1.6B in 2025 (2184.8% over 36 years). Operating cash flow compound annual growth rate: 5-year CAGR of -5.1%, 10-year CAGR of 5.3%, 20-year CAGR of 5.4%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$29.89B
Implied Share Price
$368.16
Enterprise Value
$35.77B
Revenue (TTM)
$14.59B
EBITDA
$2.35B
Profit Margin
6.88%
Trailing P/E
30.18
Forward P/E
18.66
Price/Book (MRQ)
3.31
Price/Sales (TTM)
2.05
EV/EBITDA
16.53
EV/Revenue
2.45
Dividend Yield
0.80%
Book Value
$108.96
Free Cash Flow (FY2025)
$1.21B
Free Cash Flow Yield
4.03%

Snapshot as of 30th October 2026 — not point-in-time controlled, may lag the live market by a few days.